Q3 2024 Earnings Forecast for Apogee Therapeutics, Inc. Issued By Wedbush (NASDAQ:APGE)
Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) – Wedbush reduced their Q3 2024 earnings per share estimates for Apogee Therapeutics in a note issued to investors on Monday, August 12th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings per share of ($0.70) for the quarter, down from their prior estimate of […]
More Stories
StockNews.com Begins Coverage on Golden Minerals (NYSE:AUMN)
StockNews.com began coverage on shares of Golden Minerals (NYSE:AUMN – Free Report) in a research note issued to investors on...
StockNews.com Initiates Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)
StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Friday. The...
StockNews.com Initiates Coverage on América Móvil (NYSE:AMX)
StockNews.com initiated coverage on shares of América Móvil (NYSE:AMX – Free Report) in a research note released on Friday morning....
Primerica (NYSE:PRI) Rating Increased to Buy at StockNews.com
StockNews.com upgraded shares of Primerica (NYSE:PRI – Free Report) from a hold rating to a buy rating in a research...
Zovio (NYSE:ZVO) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Zovio (NYSE:ZVO – Free Report) in a research note released on Friday. The brokerage...
StockNews.com Begins Coverage on Phoenix New Media (NYSE:FENG)
StockNews.com started coverage on shares of Phoenix New Media (NYSE:FENG – Free Report) in a research note issued to investors...